Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02439060 · ClinicalTrials.gov registry record · NA
PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT02439060 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 156 participants.
The verdict
NCT02439060, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
This randomized phase III trial studies how well biologic mesh works in preventing parastomal hernia in patients with bladder cancer who are undergoing radical cystectomy, or removal of the bladder, and ileal conduit diversion. An ileal conduit is a tube created from your small intestine that will be used as a tube for urine to flow out of your body. Parastomal hernia is a type of hernia that can occur in the stomach area where the ileal conduit is placed. Biologic mesh may help prevent parastomal hernia following surgery and ileal conduit diversion.
Interventions
- OTHER Acellular Cadaveric Dermal Matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2015-11-25 |
| Est. Completion | 2024-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02439060
The ClinicalTrials.gov registry entry for NCT02439060 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acellular Cadaveric Dermal Matrix is the first listed.
NCT02439060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02439060 about?
NCT02439060 is a clinical study titled "PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)". This randomized phase III trial studies how well biologic mesh works in preventing parastomal hernia in patients with bladder cancer who are undergoing radical cystectomy, or removal of the bladder, and ileal conduit diversion. An ileal conduit is a tube created from your small intestine that will b...
What is the current status of trial NCT02439060?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2015-11-25. Estimated completion is 2024-06-07.
What interventions are being tested in trial NCT02439060?
The interventions under investigation include: Acellular Cadaveric Dermal Matrix (OTHER).
Who is sponsoring clinical trial NCT02439060?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.